RYTHM Inc (Nasdaq: RYM) posts record Q2 with $23,021k revenue and profit
Rhea-AI Filing Summary
RYTHM, Inc. reported a record second quarter for the period ended June 30, 2026. Revenue was $23,021k (amounts in thousands of U.S. dollars), with management noting 73% sequential growth, exceeding prior guidance of 65%. Gross profit reached $18,536k, producing operating income from continuing operations of $1,936k and income from continuing operations of $1,184k, or $0.09 per diluted share. Adjusted EBITDA was $6,357k, compared with a loss a year earlier.
For the first half of 2026, revenue totaled $36,307k and net income $21,106k. Operating cash flow was positive at $9,697k, and the balance sheet showed cash of $41,915k against current related-party debt of $72,000k and total equity of $39,087k. Management highlighted accelerating demand for THC beverages, expanded partnerships with venues such as Lollapalooza and Opry Entertainment Group, and reiterated confidence in the category while cautioning that pending federal restrictions on hemp-derived THC products, effective November 2026, create regulatory uncertainty.
Positive
- Q2 2026 revenue reached $23,021k with income from continuing operations of $1,184k, turning profitable versus a loss in 2025 and described by management as a record quarter with 73% sequential revenue growth.
- Adjusted EBITDA improved to $6,357k in Q2 2026 from a negative figure in 2025, and operating cash flow for the first half of 2026 was positive at $9,697k, indicating materially stronger underlying performance than the prior year.
Negative
- The balance sheet shows current related-party debt of $72,000k plus $8,623k of other current debt, a sizable liability relative to total equity of $39,087k.
- Forward-looking statements highlight the risk that federal prohibition on hemp-derived THC products could take effect in November 2026, which may significantly affect the company’s core THC beverage and product category.
8-K Event Classification
Key Figures
Key Terms
Adjusted EBITDA financial
non-GAAP financial measures financial
discontinued operations financial
deferred tax assets financial
hemp-derived THC products regulatory
exceptional items financial
Earnings Snapshot
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
How did RYTHM, Inc. (RYM) perform financially in Q2 2026?
What were RYTHM, Inc. (RYM)’s results for the first half of 2026?
What is RYTHM, Inc. (RYM)’s liquidity and debt position as of June 30, 2026?
How did RYTHM, Inc. (RYM)’s profitability and Adjusted EBITDA change year over year?
What growth drivers did RYTHM, Inc. (RYM) highlight for Q2 2026?
What key regulatory risk does RYTHM, Inc. (RYM) face regarding hemp-derived THC products?
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM
CURRENT REPORT
Pursuant to Section 13 OR 15(d)
of The Securities Exchange Act of 1934
Date of report (Date of earliest event reported):
(Exact name of registrant as specified in its charter)
| (State or other jurisdiction | (Commission File Number) | (IRS Employer | ||
| of incorporation) | Identification No.) |
| (Address of principal executive offices) | (Zip Code) |
Registrant’s telephone number, including
area code: (
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class | Trading symbol(s) | Name of each exchange on which registered | ||
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company
If an emerging growth company, indicate by check
mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting
standards provided pursuant to Section 13(a) of the Exchange Act.
Item 2.02. Results of Operations and Financial Condition.
On August 4, 2026, RYTHM, Inc. (the “Company”) issued a press release announcing financial results for the quarter ended June 30, 2026. A copy of the release is attached as Exhibit 99.1.
The information furnished pursuant to this Item 2.02, including Exhibit 99.1, is not deemed to be “filed” for purposes of Section 18 of the Exchange Act, or otherwise subject to the liability of that section. This information will not be deemed to be incorporated by reference into any filing under the Securities Act or the Exchange Act, except to the extent that the registrant specifically incorporates them by reference.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits.
| Exhibit Number |
Title | |
| 99.1 | Press Release of RYTHM, Inc. dated August 4, 2026 | |
| 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document). |
1
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| RYTHM, INC. | ||
| Date: August 4, 2026 | By: | /s/ Brad Asher |
| Brad Asher | ||
| Chief Financial Officer |
2
Exhibit 99.1
RYTHM, Inc. Reports Second Quarter 2026 Results
ROLLING MEADOWS, IL, August 4, 2026 (GLOBE NEWSWIRE) – RYTHM, Inc. (Nasdaq: RYM) (“RYTHM” or the “Company”), America’s THC Company whose portfolio of trusted THC brands includes RYTHM, Señorita, incredibles, Beboe, and Dogwalkers, today announced financial results for the second quarter ended June 30, 2026.
Highlights for the second quarter ended June 30, 2026:
| ● | Revenue from continuing operations of $23.0 million, up 73% from $13.3 million in the prior quarter. |
| ● | Cash increased to $41.9 million driven by cash flow from operations of $8.7 million. |
| ● | Net income of $1.2 million. |
| ● | Adjusted EBITDA of $6.4 million compared to approximately breakeven in the prior quarter. |
| ● | At quarter end, the Company had approximately 2.2 million shares outstanding, as well as 11.0 million warrants outstanding and 3.0 million shares issuable upon conversion of outstanding convertible notes (excluding shares issuable upon conversion from accrued interest). |
See definitions and reconciliation of non-GAAP measures elsewhere in this release.
Recent Developments
| ● | Fixed annual cash licensing fees of $70 million from Green Thumb Industries Inc. took effect April 1, 2026. |
| ● | Señorita named the official THC beverage partner of Lollapalooza music festival and Opry Entertainment Group venues, and RYTHM the official THC beverage partner of Chicago’s Navy Pier, expanding the Company’s existing brand presence at premier live entertainment destinations across the country. |
| ● | THC beverage depletions1 increased to a record of approximately 25,000 cases across 18 states in the month of June, compared to approximately 7,000 in June 2025. |
| ● | Hemp-derived product revenue increased 67% sequentially, driven by continued growth in THC beverage distribution and direct-to-consumer channels. |
| ● | Due to uncertainty stemming from forthcoming changes in federal law affecting hemp-derived THC products, scheduled to take effect November 12, 2026, the Company is not providing an outlook for the third quarter of 2026 at this time. |
Management Commentary
“The Company delivered a record second quarter, with revenue growing 73% sequentially and exceeding prior guidance of 65% growth. This performance reflects accelerating momentum in THC beverages and the first full quarter of our amended licensing agreement with Green Thumb Industries,” said RYTHM, Inc. Chairman and Interim Chief Executive Officer Ben Kovler. “That strength was underscored by robust depletion growth across the category, a clear signal of real consumer demand for THC beverages sold in traditional retail channels, including liquor, convenience, and grocery.”
| 1 | Depletions represent U.S. distributor shipments of the Company’s branded THC beverages to retailers, measured in 24-can case equivalents, based on third-party data. |
“The quarter was also defined by the growing role of THC beverages in premier live entertainment venues, as we continued to expand our partnership roster. New collaborations with Lollapalooza music festival, Opry Entertainment Group and Chicago’s Navy Pier bring Señorita and RYTHM to some of the most storied stages in America, reflecting a broader shift in how leading venues and concessionaires are responding to evolving consumer preferences for a non-alcoholic alternative. As America’s THC Company, we are meeting consumers wherever they gather — from everyday moments to memorable occasions.”
“As we move through the summer season, we recognize the regulatory environment for THC beverages remains uncertain, with limited near-term visibility. That said, there is no wavering in our conviction on the long-term viability of this category and the durability of the demand behind it. In this dynamic operating environment, we remain focused on the factors within our control: executing with discipline and continuing to build iconic brands that consumers trust. With a scalable platform now in place, the Company has multiple paths to realize the long-term value of America’s leading portfolio of THC brands.”
The Company’s products are available direct to consumers at the following websites:
| ● | Señorita THC Margaritas: https://www.senoritadrinks.com/ |
| ● | 1777 by Señorita: https://www.1777spirit.com |
| ● | RYTHM Beverages: https://rythmdrinks.com/ |
| ● | incredibles Edibles: https://iloveincredibles.com/ |
| ● | Beboe Edibles: https://beboe.com/ |
Non-GAAP Financial Information
This press release includes certain non-GAAP financial measures as defined by the U.S. Securities and Exchange Commission. Reconciliations of these non-GAAP financial measures to the most directly comparable financial measure calculated and presented in accordance with generally accepted accounting principles (“GAAP”) are included in the financial schedules attached to this press release. This information should be considered as supplemental in nature and not as a substitute for, or superior to, any measure of performance prepared in accordance with GAAP.
Definitions
EBITDA: Income (loss) from continuing operations before: net interest (expense) income, provision for income taxes, and depreciation and amortization.
Adjusted EBITDA: EBITDA before stock-based compensation, change in fair value of warrant liabilities and exceptional items.
About RYTHM, Inc.
RYTHM, Inc.’s portfolio of THC brands includes the most recognized and trusted names in the cannabis and hemp industries, including RYTHM, incredibles, Dogwalkers, Beboe, Señorita THC Margaritas, &Shine, Doctor Solomon’s, and Good Green. With products available in thousands of physical locations and online, supported by an iconic lineup of brands rooted in quality and safety, RYTHM, Inc. is cementing its position as America’s THC Company. Through a focus on innovation, the Company is continually shaping THC experiences to meet the evolving preferences of consumers across the country. Learn more and explore the full brand portfolio at https://rythminc.com/.
2
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 concerning RYTHM, Inc. and other matters. All statements contained in this press release that do not relate to matters of historical fact should be considered forward-looking statements including, without limitation, statements regarding future financial results, regulatory trends, potential annual licensing revenue, continued momentum for hemp-derived beverages, potential trends in the hemp-derived beverage and alcohol markets, and consumer trends. In some cases, you can identify forward-looking statements by terms such as “may,” “will,” “should,” “expects,” “plans,” “anticipates,” “could,” “intends,” “targets,” “projects,” “contemplates,” “believes,” “estimates,” “predicts,” “potential,” “opportunity,” “looms” or “continue” or the negative of these terms or other similar expressions. The forward-looking statements in this press release are only predictions. We have based these forward-looking statements largely on our current expectations and projections about future events and financial trends that we believe may affect our business, financial condition and results of operations. Forward-looking statements involve known and unknown risks, uncertainties and other important factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. You should carefully consider the risks and uncertainties that affect our business, including the risk that Congress does not amend or repeal the pending federal prohibition on hemp-derived THC products prior to its November 2026 effective date as well as those described in our filings with the Securities and Exchange Commission (“SEC”), including under the caption “Risk Factors” in our most recent Annual Report on Form 10-K, which can be obtained on the SEC website at www.sec.gov. These forward-looking statements speak only as of the date of this communication. Except as required by applicable law, we do not plan to publicly update or revise any forward-looking statements, whether as a result of any new information, future events or otherwise. You are advised, however, to consult any further disclosures we make on related subjects in our public announcements and filings with the SEC.
Investor Contact
IR@RYTHMinc.com
Media Contact
Media@RYTHMinc.com
3
RYTHM Inc.
Highlights from Unaudited Condensed Consolidated Statements of Operations
For the Three and Six Months Ended June 30, 2026 and 2025
(Amounts Expressed in Thousands of United States Dollars, Except for Share Amounts)
| Three months ended June 30, | Six months ended June 30, | |||||||||||||||
| 2026 | 2025 | 2026 | 2025 | |||||||||||||
| (Unaudited) | (Unaudited) | (Unaudited) | (Unaudited) | |||||||||||||
| Revenue | $ | 23,021 | $ | 2,042 | $ | 36,307 | $ | 2,580 | ||||||||
| Cost of goods sold | 4,485 | 1,360 | 7,374 | 1,808 | ||||||||||||
| Gross profit | 18,536 | 682 | 28,933 | 772 | ||||||||||||
| Operating expenses | 16,600 | 7,480 | 31,031 | 11,271 | ||||||||||||
| Operating income (loss) from continuing operations | 1,936 | (6,798 | ) | (2,098 | ) | (10,499 | ) | |||||||||
| Other (expense) income, net | (1,957 | ) | (407 | ) | (3,594 | ) | 20 | |||||||||
| Loss from continuing operations before income taxes | (21 | ) | (7,205 | ) | (5,692 | ) | (10,479 | ) | ||||||||
| Income tax benefit | 1,205 | — | 26,798 | — | ||||||||||||
| Income (loss) from continuing operations, net of income taxes | 1,184 | (7,205 | ) | 21,106 | (10,479 | ) | ||||||||||
| Income (loss) from discontinued operations, net of income taxes | — | (155 | ) | — | 1,493 | |||||||||||
| Net income (loss) | $ | 1,184 | $ | (7,360 | ) | $ | 21,106 | $ | (8,986 | ) | ||||||
| Basic income (loss) per share | ||||||||||||||||
| Continuing operations | $ | 0.09 | $ | (3.66 | ) | $ | 1.61 | $ | (5.35 | ) | ||||||
| Discontinued operations | — | (0.08 | ) | — | 0.76 | |||||||||||
| Net income (loss) per share attributable to Common Stockholders – basic | $ | 0.09 | $ | (3.74 | ) | $ | 1.61 | $ | (4.59 | ) | ||||||
| Diluted income (loss) per share | ||||||||||||||||
| Continuing operations | $ | 0.09 | $ | (3.66 | ) | $ | 1.49 | $ | (5.35 | ) | ||||||
| Discontinued operations | — | (0.08 | ) | — | 0.76 | |||||||||||
| Net income (loss) per share attributable to Common Stockholders – diluted | $ | 0.09 | $ | (3.74 | ) | $ | 1.49 | $ | (4.59 | ) | ||||||
| Weighted average common shares outstanding - basic | 2,155,721 | 1,965,425 | 2,152,443 | 1,958,724 | ||||||||||||
| Weighted average common shares outstanding - diluted | 2,283,971 | 1,965,425 | 5,252,126 | 1,958,724 | ||||||||||||
4
RYTHM Inc.
Highlights from Unaudited Condensed Consolidated Balance Sheet
(Amounts Expressed in Thousands of United States Dollars)
| June 30, 2026 | ||||
| (Unaudited) | ||||
| Cash and cash equivalents | $ | 41,915 | ||
| Other current assets | 14,480 | |||
| Goodwill | 9,713 | |||
| Intangible assets and related party prepaid license rights | 42,475 | |||
| Deferred tax assets | 26,798 | |||
| Total assets | $ | 135,381 | ||
| Accounts payable and accrued expenses | $ | 12,804 | ||
| Related party debt, current | 72,000 | |||
| Long-term debt, current | 8,623 | |||
| Current liabilities associated with discontinued operations | 2,043 | |||
| Total long-term liabilities | 824 | |||
| Total equity | 39,087 | |||
| Total liabilities and equity | $ | 135,381 | ||
5
RYTHM Inc.
Highlights from the Condensed Consolidated Statement of Cash Flows
For the Six Months Ended June 30, 2026 and 2025
(Amounts Expressed in Thousands of United States Dollars)
| Six months ended June 30, | ||||||||
| 2026 | 2025 | |||||||
| (unaudited) | (unaudited) | |||||||
| Cash flows (used in) provided by | ||||||||
| Operating activities | $ | 9,697 | $ | (15,138 | ) | |||
| Investing activities | $ | — | $ | (5,075 | ) | |||
| Financing activities | — | 29,999 | ||||||
| Net increase in cash and cash equivalents | $ | 9,697 | $ | 9,786 | ||||
6
RYTHM Inc.
Supplemental Information (Unaudited) Regarding Non-GAAP Financial Measures
For the Three and Six Months Ended June 30, 2026 and 2025
(Amounts Expressed in Thousands of United States Dollars)
| Three months ended June 30, | Six months ended June 30, | |||||||||||||||
| 2026 | 2025 | 2026 | 2025 | |||||||||||||
| (unaudited) | (unaudited) | (unaudited) | (unaudited) | |||||||||||||
| Income (loss) from continuing operations, net of income taxes | $ | 1,184 | $ | (7,205 | ) | $ | 21,106 | $ | (10,479 | ) | ||||||
| Interest expense, net | 1,727 | 291 | 3,469 | 290 | ||||||||||||
| Income tax benefit | (1,205 | ) | — | (26,798 | ) | — | ||||||||||
| Depreciation and amortization | 3,481 | 399 | 6,925 | 735 | ||||||||||||
| Earnings before interest, taxes, depreciation and amortization (EBITDA) (non-GAAP measure) | 5,187 | (6,515 | ) | 4,702 | (9,454 | ) | ||||||||||
| Stock-based compensation expense | 578 | 515 | 1,148 | 1,104 | ||||||||||||
| Change in fair value of warrant liabilities | 232 | 115 | 127 | (292 | ) | |||||||||||
| Exceptional items1 | 360 | 437 | 360 | 437 | ||||||||||||
| Adjusted EBITDA (non-GAAP measure) | $ | 6,357 | $ | (5,448 | ) | $ | 6,337 | $ | (8,205 | ) | ||||||
| 1 | Exceptional items correspond to costs incurred outside the ordinary course of business, including transition, restructuring, or other dislocation costs arising from or related to resizing initiatives, distributor termination fees, and other similar items. |
7